Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, C

Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Cytogenetics is a branch of science, which deals with the study of cytology and genetics in coordination. Cytology includes the study of components of cells such as chromosomes, whereas genetics is the study of arrangement of genes of an individual. Thus, cytogenetics is applied in the detection and treatment of genetic disorders. The detection is based anomalies in the chromosomal patterns such as missing chromosomes, extra chromosomes, and others. These genetic disorders include cancer, cystic fibrosis, sickle cell anemia, Huntington’s disease, and others. Moreover, cytogenetics is an approach used to formulate targeted cancer therapies and personal medicines.

The global cytogenetics market was valued at $1,121 million in 2017, and is projected to reach $3,097 million by 2025 at a CAGR of 13.5% from 2018 to 2025. The growth of this market is majorly driven by increase in incidence of genetic disorders and cancer. In addition, rise in focus on targeted cancer treatment, surge in geriatric population, and rise in prevalence of chronic diseases significantly contribute the growth of the market. However, lack of awareness about cytogenetics hinders the growth of the global market. Conversely, high market potential in the untapped emerging economies is anticipated to serve as an attractive opportunity during the forecast period.
The global cytogenetics market is segmented into product, technique, application, end user, and region. On the basis of product, the market is categorized into consumables, instruments, and software & services. By technique, it is divided into comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others. The applications covered in this study include genetic disorders, cancer, personalized medicine, and others. Depending on end user, the market is fragmented into clinical & research laboratories, pharmaceutical and biotechnology companies, academic research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global cytogenetics market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
A comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on global and regional scales are provided.
The profiles of key players and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments

By Product

Consumables
Testing Kits, Media, and Reagents
Probes
Others(Affinity Reagents and Stains)
Instruments
Software & Services

By Techniques

Comparative Genomic Hybridization
Fluorescence in Situ Hybridization
Karyotyping
Immunohistochemistry
Others

By Application

Genetic Disorders
Cancer
Personalized Medicine
Others

By End User

Clinical & Research Laboratories
Pharmaceutical & Biotechnology Companies
Academic Research Institutes
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories Abbott Laboratories
Agilent Technologies, Inc.
Applied Spectral Imaging, Inc.
Empire Genomics, LLC
Illumina, Inc.
Irvine Scientific.

OPKO Health, Inc. (GeneDx.)

PerkinElmer Inc.
Sysmex Corporation (Oxford Gene Technology)
Thermo Fisher Scientific, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
MetaSystems


Chapter 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
Chapter 4 CYTOGENETICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. Consumable
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type
4.2.2.1. Testing kits, media, and reagents
4.2.2.1.1. Market size and forecast
4.2.2.2. Probes
4.2.2.2.1. Market size and forecast
4.2.2.3. Others(affinity reagents and stains)
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Instrument
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & service
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Comparitive genome hybridization
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Fluorescence in situ hybridization
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Karyotyping
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Immunohistochemistry
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
Chapter 6 CYTOGENETICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Genetic disorder
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Personalized medicine
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Other
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
Chapter 7 CYTOGENETICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Clinical and research laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Pharmaceutical and biotechnology company
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Academic Research Institute
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
7.5. Other
7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country
Chapter 8 CYTOGENETICS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast
8.2.2.1. U.S. market size and forecast
8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user
8.2.2.2. Canada market size and forecast
8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user
8.2.2.3. Mexico market size and forecast
8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user
8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast
8.3.2.1. Germany market size and forecast
8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user
8.3.2.2. France market size and forecast
8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user
8.3.2.3. UK market size and forecast
8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user
8.3.2.4. Italy market size and forecast
8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user
8.3.2.5. Spain market size and forecast
8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user
8.3.2.6. Rest of Europe market size and forecast
8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user
8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast
8.4.2.1. Japan market size and forecast
8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user
8.4.2.2. China market size and forecast
8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user
8.4.2.3. India market size and forecast
8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user
8.4.2.4. Australia market size and forecast
8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user
8.4.2.5. South Korea market size and forecast
8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user
8.4.2.6. Rest of Asia-Pacific market size and forecast
8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast
8.5.2.1. Brazil market size and forecast
8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user
8.5.2.2. Saudi Arabia market size and forecast
8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user
8.5.2.3. South Africa market size and forecast
8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user
8.5.2.4. Rest of LAMEA market size and forecast
8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user
Chapter 9 COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. Agilent Technologies, Inc.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. Applied Spectrial Imaging, Inc.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. Empire Genomics, LLC
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. Illumina, Inc.
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. Irvine Scientific
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. OPKO Health, Inc.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. PerkinElmer, Inc.
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. Sysmex Corporation
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook